BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 458006)

  • 21. Basal cell carcinoma, arising within a granular cell-type fibrous papule.
    Torre K; Larsen A; Kristjansson A; Murphy M
    J Cutan Pathol; 2016 Dec; 43(12):1245-1247. PubMed ID: 27774642
    [No Abstract]   [Full Text] [Related]  

  • 22. Basal cell and squamous cell carcinoma occurring within a field of multiple tumors of the follicular infundibulum.
    MacGregor JL; Campanelli C; Friedman PC; Desciak E
    Dermatol Surg; 2008 Nov; 34(11):1567-70. PubMed ID: 18823351
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combination of apocrine duct squamous cell carcinoma, basal cell epithelioma and sebaceous cell differentiation].
    Kishimoto S; Arita T; Koishi K; Hirano S; Tsuboi T
    Nihon Hifuka Gakkai Zasshi; 1987 Apr; 97(5):537-44. PubMed ID: 3613216
    [No Abstract]   [Full Text] [Related]  

  • 24. Proceedings: Use of 5 fluorouracil in the topical therapy of skin cancer: a review of 157 patients.
    Litwin MS; Ryan RF; Ichinose H; Reed RR; Kremetz ET
    Proc Natl Cancer Conf; 1972; 7():549-61. PubMed ID: 4764922
    [No Abstract]   [Full Text] [Related]  

  • 25. [Multiple primary cancers in blackfoot endemic area: report of a case].
    Chen KS; Huang CC; Liaw CC; Chen TJ
    Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1125-8. PubMed ID: 2853200
    [No Abstract]   [Full Text] [Related]  

  • 26. Solitary sebaceous nevus of Jadassohn complicated by squamous cell carcinoma and basal cell carcinoma.
    Arshad AR; Azman WS; Kreetharan A
    Head Neck; 2008 Apr; 30(4):544-8. PubMed ID: 17972311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of cancer in a child with ocular xeroderma pigmentosa (XP) in Malawi.
    Schulze Schwering M; Chagaluka G; Molyneux E
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e540-2. PubMed ID: 24390455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorouracil-Induced Reactive Follicular Squamous Cell Carcinoma.
    Meeks NM; Burden JG; Carroll BT
    Dermatol Surg; 2016 Aug; 42(8):1008-11. PubMed ID: 27467231
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel.
    Miller BH; Shavin JS; Cognetta A; Taylor RJ; Salasche S; Korey A; Orenberg EK
    J Am Acad Dermatol; 1997 Jan; 36(1):72-7. PubMed ID: 8996264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basal cell epitheliomas developing in a localized linear epidermal nevus.
    Goldberg HS
    Cutis; 1980 Mar; 25(3):295-7, 299. PubMed ID: 7357891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RF - Intralesional 5-Fluorouracil in the Treatment of Nonmelanoma Skin Cancer.
    Gil-Lianes J; Morgado-Carrasco D
    Actas Dermosifiliogr; 2023 Mar; 114(3):255-256. PubMed ID: 36113608
    [No Abstract]   [Full Text] [Related]  

  • 32. Basal cell epithelioma arising in a linear epidermal nevus.
    Horn MS; Sausker WF; Pierson DL
    Arch Dermatol; 1981 Apr; 117(4):247. PubMed ID: 7212753
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the treatment of superficial neoplasms with 5-FU ointment. Preliminary review].
    Bergonzini R; Vaccari R; Zagnoli P
    G Ital Dermatol Minerva Dermatol; 1970 Feb; 45(2):78-9. PubMed ID: 5467619
    [No Abstract]   [Full Text] [Related]  

  • 34. Histologic changes in superficial basal cell epithelioma and Bowen's disease by intralesional injection of recombinant interleukin 2: recombinant interleukin 2 may induce redifferentiation of malignant tumor cells in vivo.
    Mihara M; Nakayama H; Nakamura K; Morimura T; Hagari Y; Shimao S
    Arch Dermatol; 1990 Aug; 126(8):1107. PubMed ID: 2383040
    [No Abstract]   [Full Text] [Related]  

  • 35. A case in which the association between basal cell epithelioma and histiocytoma is demonstrated.
    Alinovi A; Benoldi D
    Cutis; 1982 Apr; 29(4):382-4. PubMed ID: 6282540
    [No Abstract]   [Full Text] [Related]  

  • 36. Basal cell nevus syndrome and adenocarcinoma of the colon. Response to systemic fluorouracil.
    Stone SP
    Int J Dermatol; 1979 Jun; 18(5):398-401. PubMed ID: 468461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis.
    Neale H; Michelon M; Jacob S; Pinkston M; Ukaegbu R; Zamor W; Morrison E; Deng A; Levin NA
    J Am Acad Dermatol; 2022 Aug; 87(2):423-425. PubMed ID: 34478783
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
    Weinstock MA; Thwin SS; Siegel JA; Marcolivio K; Means AD; Leader NF; Shaw FM; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin GP; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri JE; Robinson-Bostom L; Ringer RJ; Lew RA; Ferguson R; DiGiovanna JJ; Huang GD;
    JAMA Dermatol; 2018 Feb; 154(2):167-174. PubMed ID: 29299592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: 5-Fluoro-uracil 5 per cent (Efudix).
    Leeming JA
    S Afr Med J; 1973 Sep; 47(34):1520. PubMed ID: 4734019
    [No Abstract]   [Full Text] [Related]  

  • 40. Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers.
    Mansell PW; Litwin MS; Ichinose H; Krementz ET
    Cancer Res; 1975 May; 35(5):1288-94. PubMed ID: 1120313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.